Evidence map›Paper›PMID 42283596›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2026

PEDOT: PSS for Implantable and Wearable Bioelectronics: From Material Engineering and Energy Storage to Clinical Translation.

Zekun Ma, Ying Zhang, Zhou Li, Zhaoxu Meng, He Lian

Abstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zekun MaDepartment of Biomedical Engineering, School of Medical Devices, Shenyang Pharmaceutical University, Shenyang, China.
Ying ZhangDepartment of Biomedical Engineering, School of Medical Devices, Shenyang Pharmaceutical University, Shenyang, China.
Zhou LiVita Tech Innovation Center, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China.ORCID 0000-0002-9952-7296
Zhaoxu MengDepartment of Biomedical Engineering, School of Medical Devices, Shenyang Pharmaceutical University, Shenyang, China.
He LianDepartment of Biomedical Engineering, School of Medical Devices, Shenyang Pharmaceutical University, Shenyang, China.ORCID 0000-0002-2815-1922

Funding

Liaoning Province Revitalization Talent Program XLYC2503189National Key Research and Development Program 2024YFF1206200National Natural Science Foundation of China 32571629Natural Science Foundation of Liaoning Province 2024011874-JH4/4800Scientific Research Projects of Liaoning Provincial Department of Education LJ212410163004
6 · The paper itself

Abstract

Poly(3,4-ethylenedioxythiophene): polystyrene sulfonate (PEDOT: PSS), distinguished by its exceptional electrical conductivity, superior biocompatibility, and capacity for multifunctional integration, has emerged as a pivotal biomaterial at the nexus of biomedical engineering and flexible electronics. This review systematically elucidates the fundamental physicochemical attributes and charge transport mechanisms of PEDOT: PSS. It critically examines mainstream modification strategies-including solvent doping, surfactant engineering, nanocomposite formulation, and plasma treatment-providing deep insights into how these approaches govern the material's microstructure and macroscopic performance. Building on this foundation, we detail recent breakthroughs in frontier applications such as biosensing and real-time monitoring, electroceuticals, tissue engineering and regenerative medicine, smart targeted drug delivery, and self-powered wearable devices. Special emphasis is placed on the synergistic interplay among performance optimization, modification strategies, and clinical translation. Furthermore, the article offers a critical analysis of persistent challenges hindering clinical adoption, including long-term stability, biosafety, and batch-to-batch consistency. Finally, we outline future trajectories, such as counterion substitution, biomimetic interface functionalization, and intelligent closed-loop systems. This work aims to establish a robust theoretical and technical framework to accelerate the advanced research and broad deployment of PEDOT: PSS in biomedical contexts.

Indexed as

Bridged Bicyclo Compounds, HeterocyclicPolymersPolystyrenesProstheses and ImplantsTranslational Research, BiomedicalWearable Electronic DevicesHumansThiophenesTissue EngineeringBridged Bicyclo Compounds, Heterocyclicpoly(3,4-ethylene dioxythiophene)poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate)PolymersPolystyrenespolystyrene sulfonic acidThiophenesbiomedical devicesconductive polymermaterial modificationpoly(3,4‐ethylenedioxythiophene): polystyrene sulfonate

Identifiers

PMID42283596
PMCPMC13392738

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.